WebAbstract Book: 25th Congress of the European Hematology Association Virtual Edition, 2024. HemaSphere 4 ():p 1-1168, June 2024. DOI: 10.1097/HS9.0000000000000404. … WebA Review of Selected Presentations From the 2024 ASCO Annual Meeting and the EHA25 Congress . ... Abstract presented at: the 25th European Hematology Association Congress; June 11-21, 2024. Abstract S183. 15. Tefferi A, Lasho TL, Begna KH, et al. A pilot study of the telomerase inhibitor imetelstat for myelofibrosis.
Preparing for the EHA25 — Highlights from 2024 and abstracts …
WebJun 17, 2024 · The recently developed prognostic tool VTE-BLEED failed to predict bleeding complications in patients with venous thromboembolism (VTE) undergoing conventional … WebJun 17, 2024 · Presented at: Virtual Edition of the 25th European Hematology Association (EHA) Annual Congress; June 2024. Abstract LB2603. Isatuximab-irfc (Sarclisa) [package insert]. Bridgewater, NJ: sanofi ... ceidg gov
UPDATED INTERIM ANALYSIS OF THE GMMG-CONCEPT …
WebJun 17, 2024 · A randomized, double-blind, placebo-controlled study of venetoclax with azacitidine vs azacitidine in treatment-naïve patients with acute myeloid leukemia ineligible for intensive therapy –... WebOct 1, 2024 · In two presentations presented at EHA25 Virtual, the 25th European Hematology Association Annual Congress, investigators shared updates on two kinase inhibitors for the treatment of adults with immune thrombocytopenia (ITP): fostamatinib and rilzabrutinib. Fostamatinib: The Earlier, the Better WebAbstract Code: S183. Disclosure. Name: Uwe Platzbecker. Affiliations: Department of Hematology and Cell Therapy, University Clinic Leipzig, Leipzig, Germany Disclosure: • … ceidg.gov.pl